Sirnaomics Leadership to Speak at 7th China Renaissance Healthcare and Life Sciences Summit

Friday, October 25, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

GAITHERSBURG, Md., Oct. 24, 2019 /PRNewswire/ -- Sirnaomics Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced that management will attend the 7th China Renaissance Healthcare and Life Sciences Summit to be held in East Shanghai, China on October 31 - November 1. 

Yang (Patrick) Lu, PhD, President and Chief Executive Officer, will participate in a panel discussion titled "Bottlenecks & Outlets of Gene Therapy" on October 31 at 13:30 China time.  Dr. Lu will also be conducting one-on-one meeting during the healthcare summit.

About Sirnaomics, Inc.Sirnaomics, Inc., a leading privately held biopharmaceutical company for discovery and development of RNAi therapeutics, is headquartered in Gaithersburg, Maryland, USA, with subsidiaries in Suzhou and Guangzhou, China. The company's mission is to develop novel therapeutics to alleviate human suffering and advance patient care in areas of high unmet medical need. Members of the senior management team have a great deal of combined experience in the biopharmaceutical industry, financial, clinical and business management in both the USA and China. The company is supported by funding from institutional investors and corporate partnerships. Sirnaomics has developed a strong portfolio of intellectual property and an enriched product pipeline. The therapeutic areas of focus include oncology and anti-fibrosis, mainly liver diseases.

CONTACT:

Westwicke Healthcare Investors:Stephanie CarringtonTel: +1 646 277 1282 Email: Stephanie.Carrington@icrinc.com

Media: James Heins Tel: +1 203 682 8251Email: James.Heins@icrinc.com

Cision View original content:http://www.prnewswire.com/news-releases/sirnaomics-leadership-to-speak-at-7th-china-renaissance-healthcare-and-life-sciences-summit-300945207.html

SOURCE Sirnaomics, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store